文献速递慢性肾脏病血液净化与透析

血清多泛素化PTEN水平与美国印第安2型糖尿病患者肾功能丧失

Serum Level of Polyubiquitinated PTEN and Loss of Kidney Function in American Indians With Type 2 Diabetes.
PubMed 文献 · Am J Kidney Dis · 2021-09-22

该观察性队列研究在美国西南部美国印第安2型糖尿病或高风险患者中,探讨血清多泛素化PTEN(PTENK27polyUb)与肾功能丧失的关系。中位随访6.3年,PTENK27polyUb最高四分位组较低四分位组GFR下降≥40%风险显著增加(HR 3.95,95%CI 2.23-6.98,P<0.001);中位随访15.8年,肾衰竭风险也显著增加(HR 5.66,95%CI 1.99-16.13,P=0.001)。活检亚组中,PTENK27polyUb与肾小球基底膜宽度和系膜分数体积相关。

要点

  • 高血清PTENK27polyUb与2型糖尿病美国印第安人GFR下降≥40%和肾衰竭风险增加相关。
  • PTENK27polyUb与肾小球基底膜宽度和系膜分数体积等结构指标相关。
  • 该标志物可能反映进行性肾纤维化,但需在更广泛人群中验证。

核心结论

  • 在2型糖尿病美国印第安人中,较高的血清PTENK27polyUb水平与GFR下降和肾衰竭风险增加相关。

研究设计与样本

  • 其中77例参与者接受了科研性肾活检以评估肾脏结构指标。

主要发现

  • 中位随访6.3年,PTENK27polyUb最高四分位组(Q4)相比最低四分位组(Q1),GFR下降≥40%的风险增加(HR 3.95,95%CI 2.23-6.98,P<0.001)。
  • 中位随访15.8年,Q4组相比Q1组肾衰竭风险增加(HR 5.66,95%CI 1.99-16.13,P=0.001)。
  • 活检亚组中,基线血清PTENK27polyUb与肾小球基底膜宽度(ρ=0.370,P<0.001)和系膜分数体积(ρ=0.392,P<0.001)相关。

关键数值与推荐

  • 基线平均年龄42.8±10.5岁,糖尿病病程11.5±7.1年,平均动脉压90.5±9.5 mm Hg,HbA1c 9.3±2.4%,GFR 152±45 mL/min,尿白蛋白肌酐比中位数38(IQR 14-215)mg/g。
  • 64例(27.4%)使用肾素-血管紧张素系统阻滞剂。

临床怎么用

  • 血清PTENK27polyUb可能作为预测2型糖尿病患者肾功能进行性下降的生物标志物,但当前证据尚不足以指导临床决策。

局限性

  • 研究样本量小,且仅在单一美国印第安人群中开展,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Fibrosis is a major driver of chronic kidney disease, and epithelial-mesenchymal transition (EMT) may contribute to its development. A polyubiquitinated form of phosphatase and tensin homolog (PTENK27polyUb) promotes EMT in vitro. Thus, it is a potentially useful biomarker of progressive kidney fibrosis and may predict loss of kidney function. STUDY DESIGN: Observational cohort study. SETTING & PARTICIPANTS: Southwest United States, American Indians (154 women, 80 men) with or at high risk for diabetic kidney disease (DKD). PREDICTORS: Serum level of PTENK27polyUb. OUTCOME: ≥40% loss of glomerular filtration rate (GFR) or onset of kidney failure. Kidney structural measures in a subset of study participants who underwent research kidney biopsies (n = 77). ANALYTICAL APPROACH: Cox proportional hazards models adjusted for age, sex, diabetes duration, hemoglobin A1c (HbA1c), blood pressure, use of renin angiotensin system (RAS) blockers, measured GFR, and albuminuria. Spearman correlations for associations with structural measures. RESULTS: At baseline, the participants' mean age was 42.8 ± 10.5 (SD) years, diabetes duration 11.5 ± 7.1 years, mean arterial pressure 90.5 ± 9.5 mm Hg, HbA1c 9.3 ± 2.4%, GFR 152 ± 45 mL/min, and median urinary albumin-creatinine ratio 38 (interquartile range, 14-215) mg/g. RAS blockers were being used by 64 participants (27.4%). A higher PTENK27polyUb value was associated with a greater risk of ≥40% loss of GFR during a median follow-up period of 6.3 years (HR for quartile 4 [Q4] vs Q1, 3.95 [95% CI, 2.23-6.98], P < 0.001). Serum PTENK27polyUb was associated with an increased risk of kidney failure over a median follow-up period of 15.8 years (HR for Q4 vs Q1, 5.66 [95% CI, 1.99-16.13], P = 0.001). Baseline serum PTENK27polyUb in the biopsy subset correlated with structural measures including glomerular basement membrane width (ρ = 0.370, P < 0.001) and mesangial fractional volume (ρ = 0.392, P < 0.001). LIMITATIONS: Small study in single population. CONCLUSIONS: Higher serum PTENK27polyUb is associated with increased risk for GFR decline and kidney failure in American Indians with type 2 diabetes.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Looker HC, Lin C, Nair V, et al. Serum Level of Polyubiquitinated PTEN and Loss of Kidney Function in American Indians With Type 2 Diabetes. Am J Kidney Dis. 2021. PMID: 34562525. doi:10.1053/j.ajkd.2021.08.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。